Gene · 9563
Papers3,177
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,177
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity. | Int J Mol Sci | 2022 | 35897826 | PubTator, text mining | PubMed |
| The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention. | Int J Mol Sci | 2022 | 35897717 | PubTator, text mining | PubMed |
| The Effect of Laminaria japonica on Metabolic Syndrome: A Systematic Review of Its Efficacy and Mechanism of Action. | Nutrients | 2022 | 35893900 | PubTator, text mining | PubMed |
| Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review. | Cancers (Basel) | 2022 | 35892820 | PubTator, text mining | PubMed |
| Production of Lacto-N-biose I Using Crude Extracts of Bifidobacterial Cells. | J Appl Glycosci (1999) | 2022 | 35891897 | PubTator, text mining | PubMed |
| Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. | Pharmaceuticals (Basel) | 2022 | 35890106 | PubTator, text mining | PubMed |
| 3D-Printed Microneedles for Point-of-Care Biosensing Applications. | Micromachines (Basel) | 2022 | 35888916 | PubTator, text mining | PubMed |
| Emerging Bioanalytical Devices and Platforms for Rapid Detection of Pathogens in Environmental Samples. | Micromachines (Basel) | 2022 | 35888900 | PubTator, text mining | PubMed |
| The Effect of Host miRNAs on Prognosis in COVID-19: miRNA-155 May Promote Severity via Targeting Suppressor of Cytokine Signaling 1 (SOCS1) Gene. | Genes (Basel) | 2022 | 35885930 | PubTator, text mining | PubMed |
| The Thioredoxin System of Mammalian Cells and Its Modulators. | Biomedicines | 2022 | 35885063 | PubTator, text mining | PubMed |
| Recent Developments and Future Perspective on Electrochemical Glucose Sensors Based on 2D Materials. | Biosensors (Basel) | 2022 | 35884271 | PubTator, text mining | PubMed |
| Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency. | J Inherit Metab Dis | 2022 | 35866541 | PubTator, text mining | PubMed |
| White Spot Syndrome Virus Triggers a Glycolytic Pathway in Shrimp Immune Cells (Hemocytes) to Benefit Its Replication. | Front Immunol | 2022 | 35860260 | PubTator, text mining | PubMed |
| Glucose-1,6-Bisphosphate, a Key Metabolic Regulator, Is Synthesized by a Distinct Family of α-Phosphohexomutases Widely Distributed in Prokaryotes. | mBio | 2022 | 35856562 | PubTator, text mining | PubMed |
| G6PD Deficiency Is Crucial for Insulin Signaling Activation in Skeletal Muscle. | Int J Mol Sci | 2022 | 35806430 | PubTator, text mining | PubMed |
| The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway. | Int J Mol Sci | 2022 | 35806424 | PubTator, text mining | PubMed |
| The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection. | Cells | 2022 | 35805067 | PubTator, text mining | PubMed |
| Variation in biochemical, physiological and ecophysiological traits among the teak (Tectona grandis Linn. f) seed sources of India. | Sci Rep | 2022 | 35804090 | PubTator, text mining | PubMed |
| Glucose-6-phosphate dehydrogenase immobilized onto magnetic beads (G6PDH-Mb) as a generator system for production of NADPH: Development and application in metabolism studies. | J Pharm Biomed Anal | 2022 | 35780529 | PubTator, text mining | PubMed |
| The Growing Spectrum of DADA2 Manifestations-Diagnostic and Therapeutic Challenges Revisited. | Front Pediatr | 2022 | 35774100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9563/papers?page=28